For U.S. residents only.

Starting on TASIGNA

< Back To Site

Prescribing Info including Patient Info

IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING AND APPROVED USE

QTc Prolongation and Sudden Death: TASIGNA can cause QTc prolongation, a possibly life-threatening heart problem. QTc prolongation causes an irregular heartbeat, which may lead to sudden death. Call y...

Approved Uses:

TASIGNA^® (nilotinib) capsules is a prescription medicine used to treat:

Adults with newly diagnosed Philadelphia chromosome–positive (Ph+) chronic myeloid leukemia (CML) in chronic phase
Adults with Ph+ CML in chronic phase and accelerated phase who no longer benefit from, or ...

Watch a video for helpful tips and resources

We want you to be confident in your TASIGNA^® (nilotinib) capsules treatment journey. Watch this animated video for helpful tips and resources.

From financial coverage to dosing schedules to the Patient Navigator Program, the Starting On TASIGNA educational video has helpful information for patients.

So, let’s get started. Watch the video below.

Starting on TASIGNA Video

Here’s a sneak peek at the information you’ll find in the video

Financial Resources to help patients save on their medication

Taking TASIGNA for creating a dosing routine that works with your schedule

Novartis Patient Navigators provide one-on-one support for patients taking TASIGNA. To enroll, contact Patient Assistance Now Oncology (PANO) at 1-800-282-7630, prompt 3

Are you eligible for savings on TASIGNA?

Find out if you could save on your medication

Get one-on-one support from a Patient Navigator

Learn about the importance of monitoring and more from a Patient Navigator

Next: Taking TASIGNA